Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was initially approved ...

Global recognition honors Immunotec’s decades-long commitment to scientific discovery and continued advancement of ...

BREAKTHROUGH INNOVATION BRINGS AFFORDABLE LUXURY & COMFORT TO MAINSTREAM VEHICLES SHANGHAI, CHINA / ACCESS Newswire / ...

The FDA lifted the clinical hold on Aardvark's Investigational New Drug application for ARD-101 on October 22, 2026. The company plans to request an FDA meeting to align on a new Phase 3 trial design ...

The City of Cadillac launched a new Homeowner Rehabilitation Program funded by $653,130 in Community Development Block Grants ...

AI experts from the Artificial Intelligence Track of the UAE National Experts Program meet with AGI company AHS Technologies ...

The federal government is promoting a $2-billion investment aimed at helping Canadian families, including those in rural and ...

Youth, a program by the Greater Chambersburg Chamber Foundation, is now accepting applications from current ninth-grade ...

Korea will randomize college application numbers and change ratio disclosure from this year's regular admissions round after ...

The Minnesota Office of Cannabis Management has opened a new application period for $10.9 million in grants supporting ...

TAIPEI, Oct. 23, 2026 /PRNewswire/ -- As artificial intelligence (AI) technology continues to advance rapidly, AI is ...

Samsung Members app reveals a redesigned banner hinting that the One UI 9.5 beta program could launch sooner than expected.